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SummaηElectrophysiological effects of flecainide and ethacizin (class Ic antiarr-
hythmic drugs) were examined using conventional microelectrode techniques. Flecainide 
significantly depressed the maximum rate of depolarization (V rnax) at 3 xl0-6 M， and 
depolarized the resting potential (RP) at 10-5 M， in a concentration-dependent manner. 
Ethacizin depressed V rnax at 10-6 M， and depolarized RP at 10-5 M， significantly. However， 
both drugs did not affect the effective refractory period CERP) nor the action potential 
duration (75 % repolarization， APD75). Both also had no effect on the action potential 
amplitude (APA). On the other hand， the drugs caused a use (or rate)-dependent block 
of V rnax， and their time constants of onset of inhibition (at 3 Hz) were slow ; 6.3:t 1.2 msec 
(nニ 10)in the presence of flecainide (10-5 M)， and 6.0士1.6msec (n=6) in the presence of 
ethacizin (10-5 M). The time constants of the recovery were also so late: 12.2士2.5sec (nニ
3) for flecainide (10-5 M)， and 27.1士13.3sec (nニ 3)for ethacizin (2xl0-6 M). These results 
indicate that both antiarrhythmic drugs， flecainide and ethacizin， have no effect on APD75 
and ERP， but possess the characteristics for very slow kinetics of the use-dependent block 
and the recovery for fast N a + channels of cardiac muscles. Ethacizin produces slower 
kinetics for the Na+ channels than flecainide目
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INTRODUCTION 
The mechanisms of the use-dependent block by the class 1 antiarrhythmic drugs for fast N a + 
channels of heart muscle has been investigated1). Class Ic antiarrhythmic drugs have no effect 
on the action potential duration (APD)， and also possess characteristics for slow kinetics for 
a use-dependent block and recovery from the depression of fast N a + channels， according to a 
classification by Vaughan Williams2) and ιampbelP). Flecainide is well-known， and is classi同
fied as a class Ic antiarrhythmic drug， having characteristics of the slow kinetics4)5). 
Phenothiazines have been used in the treatment of a variety of psychiatric disorders6). The 
compounds depress the central nervous system， and their effects on autonomic nervous control 
include an antiadrenergic as well as an anticholinergic property. Phenothiazines may also 
depress the contractile performance of the heart， depress baroreceptor reflexes and exert 
antiarrhythmic effects similar to quinidine or lidocaine6)7). Ethmozin， a phenothiazine deriva同
( 6 ) H目 Satoh，et al. 
tive， exhibits powerful antiarrhythmic properties8}ー12} A diethylamine analogue of ethmozin， 
ethacizin， has been recently developed as a new antiarrhythmic drug in Russia13}14} (Fig. 1). It 
has been demonstrated that ethacizin possesses a potent antiarrhythmic action13}15}16}， and is a 
c1ass 1 antiarrhythmic agent (an inihibitory action of fast N a + channels) in mammalian 
myocardium17}. 
In the present experiments， we sought to examine the electrophysiological effects of 
ilecainide and ethacizin on the action potentials in canine ventricular musc1e. Especially， the 
association time (a use-dependent block and a resting block) and the dissociation time (a 
recovery from blockade) of the drugs binding to the fast Na+ channels were investigated. 
MATERIALS AND METHODS 
Preparations and recording 
Eleven mongrel dogs of either sex， weighing 7-10 kg， were anesthetized with sodium 
pentobarbital (30 mg/kg， i. vふ Themethods have been described in previous papers18)-20}. In 
brief， the heart was quickly excised， and the preparations (2-3 x 10-15 mm) were obtained from 
the right ventric1e. The preparations were usually driven at 1 Hz. The duration of the stimuli 
was 1-2 msec and the voltage was about 50 % above the threshold. The action potential was 
obtained by a conventional glass microelectrode technique Cits resistance was 5-10 MO)， and 
recorded (displayed) on an oscilloscope (Nihon Kohden VC-ll) and a thermal array recorder 
(Nihon Kohden， WS-641G)， or photographed (Nihon Kohden RLG6201). The refractory period 
was measured at the 11th pulse with shorter intervals by interrupting the constant stimulation 
interval of 1 sec. 
Analyses for the kinetics 
Experiments for the use-dependent block of V max were performed as represented in Fig. 2. 
The control value of V max in the absence of drug was determined. Then， the drug was 
administrated and the stimulation was stopped. Following a resting period of 90 sec， repetitive 
stimulation was resumed at the same frequency as the control. For recovery of V max inhibition， 
the stimulation at 3 Hz was stopped during exposure to drugs and the diastolic intervals were 
changed (Fig. 2). The percentage of recovery from use-dependent block was estimated by an 
equation: l-(V max)test/ (V max)町 st，where (V max) test is the value of V max at the stimulation after 
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Fig. 1. Chemical structure of ethacizin. 
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Fig目 2.Use-dependent inhibition of Na+ channel and recovery from the 
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max対imumr悶at白e0ぱfd白巴po叶la剖r包a抗tio叩n(Vma聞1阻xρ)by f臼l巴配ca討in凶1吋id巴 10-5M is r巴
pr巴s巴臼凹nt匂巴d.The preparation was driven at 3 Hz. A: Pause for 4 IDin 
duration. B: Pause for 8 min-duration. Note the difer巴nceof the V max 
recovery from th巴 depressionin A and B. 
the diastolic interval， and (V max)first is that at the first stimulation after rest during exposure 
to the drug. 
Values are given as mean土SD，and comparisons were Student's paired t test， as appropriate. 
Probability levels of less than 0.05 were taken as indicating significant differences. 
Solutions 
The composition of modified Tyrode solution (mM) was as follows: NaCl137， KC14， CaC12 
1.8， MgC12 1.， N aHC03 11.9， N aH2P04 0.45， and glucose 5.5. The pH was adjusted to 7.4 with 
NaOH. The preparations were superfused in a bath with oxygenated (95 % O2 and 5 % CO2) 
Tyrode solution. The temperature was maintained at 36'C. The drugs used were f1ecainide 
acetate (Ricker Laboratories) and ethacizin， 2-(ethoxycarbonylamino)-10一[3一Cdiethylamino)
propionyl]-phenothiazine hydrochloride， (Nikken Chemicals Ltd.). The drugs were adminis-
trated cumulatively. 
RESULTS 
Ethacizin (10-7 to 10-5 M) and f1ecainide (10-6 to 10-5 M) were cumulatively added to the 
bath solution. Both ethacizin (at over 10一7M) and f1ecainide (at over 3x10-6 M) decreased 
V max and depressed the amplitude (phase 0) of action potential， profoundly (Fig. 3A -B). The 
preparations were constantly stimulated at 1 Hz. The action potential duration at 75 % 
repolarization (APD75) and the resting potential (RP) were unaffected by both drugs. The 
percentage changes in the action potential parameters are shown in Table 1. Flecainide 
depolarized RP and depressed the action potential amplitude at 10-5 M， and inhibited V max at 
H. Satoh，巴tal目( 8 ) 
































Fig. 3. Changes in the action potential configuration 日 thepresenc!" of ethaCIzin and fl巴cainid巴 The
prepqratitns were stimulated at 1 Hz. A: Action potential and V max in etacizin. B: Action potential 
and V max in flecainide. Brief line at 1巴ftof the action potential recordings is repr巴sentedzero mV 
]100 V/s 
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Table l. Percentag巴changesin the action potential param巴tersin canine 
ventricular muscles in the presence of flecainide and ethacizin 
APA Vmox 















































10-7M 10 士1% 士2% 6土2% 0% 0% 
10-6M 10 土2 土 2土5** 4士土2
10-5M 7 6土2* 10土5 41士6刊 4土2 士3
Values represernt rnean士SD.n: N urnber of experirnents. RP: Resting Potential. 
APA: Arnplitude of action potential. V mox: Maxirnurn rate of depolarization 
APD75: Duration of action potential at 75% repolarization. ERP: Effective 
refractory period. *: P < 0.05， * * : Pく0.01，with respect to control valu巴s
216士32220土24254土21112土1088士510 
3x10-6 M or more， significantly. Ethacizin depolarized RP at 10-5 M， and inhibited V rnax at 10-6 
M or more， significantly. Both drugs did not produce any effects on the APD75 and the effective 
refractory period CERP) ， although both tended to prolong them. 
After the stimulation was stopped， the drugs were added to the bath solution. At 90 sec after 
Use-dependent block and recoverγof N a + channels by c1ass Ic antiarrhythmic drugs 
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the rest， the V max of the action potential elicited by the first stimulation was decreased by about 
10 % (concentration-dependent) as compared to control value (which is a resting block)， and 
then the V max dec1ined during stimulation to a new steady state (which is a use-or frequency-
dependent block)， as shown in Figs. 4 and 5. The actual data in the presence of f1ecainide 10-5 
M are also shown in Fig. 2A-B. The experiments were exerted at different frequencies of 
stimulations (1 to 3 Hz). The inhibition was frequency-dependent. The time constants (τ) of 
onset of inhibition of V max at different stimulation frequencies in the presence of flecainide and 
ethacizin are summaried in Table 2.τat 3 Hz was 6.3土1.2msec (n=10) in flecainide 10-5 M 
and 6.0土1.6msec (n=6) in ethacizin 10-5 M. These results indicate that ethacizin has a slow 
onset of inhibition for V max， like flecainide. 
As shown in Fig. 2， the different intervals were exerted and the recovery of the V max 
inhibition binding with N a+ channels was examined. The preparations were driven by stimula-
tion of 3 Hz. A typical example is shown in Fig. 6A-B. In the absence of drug， the recovery 
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Fig. 4. Use-dependent block by ethacizin at difer-
ent frequencies. A: B10ckade in 1O-7M ethac， 
izin. B: Blockade in 10-6M ethacizin. Sym-
bols ar巴 1Hz Copen circ1es)， 2Hz C仕iangles)
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Fig. 5. Use-dependent block by fl巴cainideat difer-
ent frequencies. A: B10ckade in 10-'M 
f1ecainide. B: B10ckade in 10-'M fl巴cainide.
Symbols are 1Hz Copen circ1巴s)，2Hz Ctri-
angles) and 3Hz Cfil1ed circ1es) 
Table 2. Time constants of onset of inhibition for V max at different 
frequencies of stimulation in the presence of flecainide 
and ethacizin 
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Fig. 6. Recovery of depressed N a + chann巴1in the presence of ethac-
izin and flecainide. Th巴datawere obtain巴dby constant stimu-
lation at 3弓z，except for the test of recov巴ryfrom the 
depression of V max・Thevalues (%) are r巴presentedalong with 
time function. A: Ethacizin (2 x 10-6M).τwas 25.7s. B 
Flecainide (10-5M).τwas 10.3s 
of V max following the basic driven action potential was complete within 50 msec， and was well 
fitted by a single exponential function with a time constant of 22土4msec (n= 8). In the 
presence of ethacizin，τfor the recovery was 26.8士17.2sec (n=4) at 10-6 and 27.1:l:13.3 sec 
(n=3) at 2x10-6 M. On the other hand， in the presence of flecainide at 10-5 M，τwas 12.2土2.
5 sec (n=3). These results indicate that ethacizin possesses much slower kinetic for recovery 
from use-dependent block， twice that of flecainide. 
DISCUSSION 
It is now well established that many class 1 antiarrhythmic drugs Clocal anesthetic type) 
depress the V max (or the fast N a + channels) of cardiac action potentials in a rate-dependent 
manner2). Their enhanced potencies at higher frequencies are thought to be brought about by 
selective binding of the drugs to inactivated N a+ channels21) or by voltage-dependent binding22). 
In a modulated receptor hypothesis21)叫， rested Na+ channels have a much lower affinity for 
antiarrhythmic drugs than depolarized (that is， activated and/or inactivated) channels. 
Furthermore， the more depolarized the holding potential is， the slower is the rate of recovery 
Use-dependent block and recov巴ryof Na+ chann巴Isby clas Ic antiarrhythmic drugs 
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from the block of the N a + channels. 
Ethmozin is an effective， safe， and well-tolerated new antiarrhythmic drug8)-12). A diethyl-
amine analogue of ethmozin， ethacizin， had a negative inotropic effect in the presence of 
muscarinic and βadrenoceptor blockades in ferret right ventricular papillary muscles叫.This 
is largely due to its recently demonstrated decreases of the slow inward Ca2十 currentin frog 
atrial trabeculae14) and canine Purl王injefibers8)14)24). Thus， ethacizin appear to be an even 
more potent antiarrhythmic drug13)15) 
The present experiments show many similarities between flecainide and ethacizin. Neither 
flecainide nor ethacizin caused any significant effects on the APD and the ERP， although with 
both drugs， minor prolongations were produced. This is consistent with the results of Smetnev 
et al，25) and Rosenshtraukh et al，l3). These results indicate that ethacizin should be considered 
a class Ic antiarrhythmic drug， like flecainide. 
On the other hand， ethacizin had almost the same kinetics as compared to those of flecainide : 
(1) slow kinetic for the onset of inhibition of V max， and (2) much slower kinetic for recovery 
from the depressed V max. Flecainide possesses well-known slow kinetics for the association 
and dissociation with Na+ channels4)5)26). The values in this study of the onset and recovery 
kinetics for flecainide are quite consistent with those reported previously. Therefore， we 
concluded that ethacizin produces the characteristics of slower kinetics for both the association 
and dissociation with fast Na+ channels of cardiac muscles. Many factors to determine the 
rates of binding (association) and dissociation with the N a+ channels are present. Drugs with 
high 1ipid solubility may produce a faster and greater block of the channels， whereas drugs with 
lower molecular weight may leave the channel more quickly during each diasto1ic interval of 
the action potentials3)27). On the contrary， Hille23) showed that the rate of block development 
correlated well with lipid solubi1ity， but not with molecular weight or size of the drug. The 
molecular weight of ethacizin is 449. 9. This is relatively large， indicating that ethacizin might 
have the slow kinetic characteristics for the channels. Courtney28) has shown that drugs having 
quite small dimensions (X， Y and Z) can gain access to the receptors during maintained 
depolarization Cinactivated state)， e 
(12 ) H. Satoh， etal. 
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